1. Home
  2. KRRO vs BGIN Comparison

KRRO vs BGIN Comparison

Compare KRRO & BGIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • BGIN
  • Stock Information
  • Founded
  • KRRO 2014
  • BGIN 2019
  • Country
  • KRRO United States
  • BGIN Singapore
  • Employees
  • KRRO N/A
  • BGIN N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • BGIN
  • Sector
  • KRRO Health Care
  • BGIN
  • Exchange
  • KRRO Nasdaq
  • BGIN Nasdaq
  • Market Cap
  • KRRO 358.3M
  • BGIN 387.8M
  • IPO Year
  • KRRO 2019
  • BGIN 2025
  • Fundamental
  • Price
  • KRRO $34.30
  • BGIN $3.79
  • Analyst Decision
  • KRRO Strong Buy
  • BGIN
  • Analyst Count
  • KRRO 8
  • BGIN 0
  • Target Price
  • KRRO $96.25
  • BGIN N/A
  • AVG Volume (30 Days)
  • KRRO 194.0K
  • BGIN 461.9K
  • Earning Date
  • KRRO 11-12-2025
  • BGIN 11-22-2025
  • Dividend Yield
  • KRRO N/A
  • BGIN N/A
  • EPS Growth
  • KRRO N/A
  • BGIN N/A
  • EPS
  • KRRO N/A
  • BGIN 0.61
  • Revenue
  • KRRO $6,281,000.00
  • BGIN $302,277,581.00
  • Revenue This Year
  • KRRO $116.91
  • BGIN N/A
  • Revenue Next Year
  • KRRO N/A
  • BGIN N/A
  • P/E Ratio
  • KRRO N/A
  • BGIN $6.39
  • Revenue Growth
  • KRRO N/A
  • BGIN 17.50
  • 52 Week Low
  • KRRO $10.29
  • BGIN $3.75
  • 52 Week High
  • KRRO $76.79
  • BGIN $6.50
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 42.32
  • BGIN N/A
  • Support Level
  • KRRO $31.17
  • BGIN N/A
  • Resistance Level
  • KRRO $42.70
  • BGIN N/A
  • Average True Range (ATR)
  • KRRO 3.80
  • BGIN 0.00
  • MACD
  • KRRO -1.37
  • BGIN 0.00
  • Stochastic Oscillator
  • KRRO 20.10
  • BGIN 0.00

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: